SiteOne Landscape Supply Announces Fourth Quarter and Full Year 2021 Earnings
Fourth Quarter 2021 Highlights (Compared to Fourth Quarter 2020): Net sales increased by 19% to…
Fourth Quarter 2021 Highlights (Compared to Fourth Quarter 2020): Net sales increased by 19% to…
TOLEDO, Ohio–(BUSINESS WIRE)–Owens Corning (NYSE: OC), a global building and construction materials leader, today reported…
Stronghold Capital’s investments will expand founder representation and access in fintech innovation SAN FRANCISCO–(BUSINESS WIRE)–Stronghold,…
Capco and Wipro FullStride Cloud Services global study finds financial services companies’ cloud goals are…
Variation Across the 2020 Dual Credit Results for Individual OEMs BOSTON–(BUSINESS WIRE)–China’s Dual Credit policy…
The network upgrades in Guernsey, Jersey, London and Paris ensure Sure’s future growth Channel Islands,…
Internet City, Dubai–(Newsfile Corp. – February 16, 2022) – LBank Exchange, a global digital asset…
Vancouver, British Columbia–(Newsfile Corp. – February 16, 2022) – NetCents Technology Inc. (CSE: NC) (FSE:…
Marks Tofane Global’s sixth acquisition in four years and accelerates iBASIS’ Internet of Things (IoT)…
Multivendor software-driven architecture showcases route to enhanced mobile business opportunities and critical user experiences SUNNYVALE,…
London–UK, Quadient a leader in helping businesses create meaningful customer connections through digital and physical…
NEW YORK, Feb. 15, 2022 (GLOBE NEWSWIRE) — Avenue Therapeutics, Inc. (NASDAQ: ATXI) (“Avenue”), a…
MALVERN, Pa., Feb. 15, 2022 (GLOBE NEWSWIRE) — Baudax Bio, Inc. (NASDAQ:BXRX) a pharmaceutical company…
LAGUNA HILLS, Calif.–(BUSINESS WIRE)–BrainChip Holdings Ltd (ASX: BRN, OTCQX: BRCHF, ADR: BCHPY) the world’s first…
MELBOURNE, Australia, Feb. 15, 2022 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the…
REDWOOD CITY, Calif., Feb. 15, 2022 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (Nasdaq: “CHRS”, “the…
TORONTO, Feb. 15, 2022 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB:…
Asserts Certara’s leadership in advancing the development and approval of new drugs for patients PRINCETON,…
HOOKIPA to develop arenaviral-based therapeutic for HIV through Phase 1b clinical trial completion; Gilead has…
SEATTLE, Feb. 15, 2022 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a…